Cipla launches Spirofy for early diagnosis for COPD, Asthma
According to Cipla, the "Spirofy" is a good battery-backed transceiver, suitable for use in outdoor campgrounds and remote areas where power is scarce. Advanc
- by Gaurav Grover 2021-11-17 09:36:55
Pharmaceutical company Cipla announced on World COPD Day the launch of India's first wireless handheld compressed air lung capacity meter, Spirofy. With this launch, the company aims to revolutionize the diagnosis of obstructive airway disease (OAD) in line with its ambition to solidify its position as India's leading lung company. This is part of the company's #LungAttack campaign aimed at raising awareness of COPD and promoting early diagnosis.
According to Cipla, the "Spirofy" is a good battery-backed transceiver, suitable for use in outdoor campgrounds and remote areas where power is scarce. Advanced devices use bacterial and viral filters to ensure high accuracy of results and individual patient safety. The company developed this device after five years of internal research.
The device can generate real-time reports, print instantly using a portable wireless thermal printer, or share a PDF copy over the phone.
Talking about the launch, Umang Vohra, Managing Director and CEO of Cipla Ltd. Cipla continues to focus on addressing the growing burden of respiratory illnesses worldwide and is fighting chronic respiratory illnesses such as COPD through this launch. The launch of DeSpirovy aims to help clinicians across the country improve their patients' lives through accurate and effective diagnosis. .. In terms of cost. "
The device can generate real-time reports, print instantly using a portable wireless thermal printer, or share a PDF copy over the phone.
Talking about the launch, Umang Vohra, Managing Director and CEO of Cipla Ltd. Cipla continues to focus on addressing the growing burden of respiratory illnesses worldwide and is fighting chronic respiratory illnesses such as COPD through this launch. The launch of DeSpirovy aims to help clinicians across the country improve their patients' lives through accurate and effective diagnosis. .. In terms of cost. "
POPULAR POSTS
Kenya Cancels Proposed Airport, Power Transmission Deals with Adani Group After US Indictments
by B2B Desk, 2024-11-22 07:11:55
Adani Group to Invest USD 2 Billion in International Convention Centre, Challenges Jio World Centre
by B2B Desk, 2024-11-20 09:19:53
Suditi Industries Acquires Iconic Kidswear Brand Gini & Jony
by B2B Desk, 2024-11-20 09:31:33
Vedanta Ltd to Invest $500 Million in Tokyo-Based Display Glass Arm AvanStrate Inc
by B2B Desk, 2024-11-14 08:23:15
EPF, EPS Contribution Limit May Be Hiked to Rs 21,000 Soon: How It Can Impact You
by B2B Desk, 2024-11-12 06:51:51
Jaishankar and Manturov to Steer India-Russia Talks: Focus on Export Imbalance and $100 Billion Trade Target by 2030
by B2B Desk, 2024-11-11 11:45:28
Will India Gain More Than It Loses Under Trump 2.0? Here's What Strategic Affairs Experts Say
by B2B Desk, 2024-11-07 07:11:07
Follow on Insta
RECENTLY PUBLISHED
HealthKart Secures $153 Million Investment from ChrysCapital and Motilal Oswal Alternates
- by B2B Desk, 2024-11-19 07:07:40
India Joins Hands with Elon Musk’s SpaceX to Launch Its Most Advanced Satellite Next Week
- by B2B Desk, 2024-11-18 08:42:51
Subscribe now
x
![logo]()
